BOTBOT was in a rather different situation where the FDA indicated that they would grant approval if some minor changes were made, so approval was pretty much already priced in. MSB seems to have a higher degree of uncertainty (personally I would like to say I am certain of approval but that wouldn't be true). Maybe 80 - 90%? So I would expect the sp to double on approval if not a bit more but hopes of a lot more seem a bit unrealistic. Of course, I hope I am wrong!
BOT BOT was in a rather different situation where the FDA...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.8¢ |
Change
-0.023(2.30%) |
Mkt cap ! $1.116B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 95.5¢ | $5.195M | 5.346M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 93632 | 95.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 172425 | 21 |
View Market Depth
| Last trade - 15.30pm 26/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |